EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF CHICAGO AND EVELO BIOSCIENCES FOR AN IMMUNO-ONCOLOGY TECHNOLOGYExclusive License Agreement • March 21st, 2018 • Evelo Biosciences, Inc. • Pharmaceutical preparations
This License Agreement (“Agreement”), dated March 10, 2016 (the “Effective Date”), is between The University of Chicago, an Illinois not-for-profit corporation (“University”), and Evelo Biosciences, Inc., a Delaware corporation, having an address at 620 Memorial Drive, Suite 200 Cambridge, Massachusetts 02139. (“Company”). Each hereunder may be referred to separately as the “Party”, or together as the “Parties”.
